GLP-1 Medications·7 min read

Ozempic vs. Wegovy in Houston: Which Semaglutide Is Right for You?

Both Ozempic and Wegovy contain semaglutide, but they are different products with different approved uses. Here's what Houston patients need to know before asking their doctor.

ET
By Editorial Team·

Reviewed for accuracy against current FDA guidance, peer-reviewed clinical trial data (STEP, SURMOUNT trials), and manufacturer prescribing information. See our editorial standards.

Ozempic and Wegovy are the same drug — semaglutide made by Novo Nordisk — but they are not interchangeable, and Houston clinics treat them very differently for good reason. Ozempic tops out at a 2mg weekly dose and carries an FDA approval for type 2 diabetes; Wegovy goes up to 2.4mg and is the only version officially approved for weight loss. That distinction matters enormously for insurance coverage, especially for patients at clinics across Katy, Sugar Land, and The Woodlands where prior authorization rules vary by plan. This article breaks down the clinical differences, what each costs out of pocket in the Houston market, and how to figure out which one your provider is likely to prescribe.

1Ozempic vs. Wegovy: The Core Difference

Ozempic (semaglutide 0.5 mg, 1 mg, and 2 mg) is FDA-approved to treat type 2 diabetes and to reduce cardiovascular risk in adults with type 2 diabetes and heart disease. It was never officially approved for weight loss, though weight reduction is a well-known side effect. Wegovy (semaglutide 2.4 mg) is FDA-approved specifically for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. The dose in Wegovy is meaningfully higher than the maximum diabetes dose in Ozempic, and the prescribing criteria are different. In clinical trials, Wegovy at 2.4 mg produced an average weight loss of 14.9% of body weight over 68 weeks.

2Why Houston Doctors Sometimes Prescribe Ozempic Off-Label for Weight Loss

Before Wegovy was widely available and affordable, many physicians across Houston began prescribing Ozempic off-label for weight loss in non-diabetic patients. This practice became widespread as demand far outpaced supply during the 2022-2023 shortage period. Off-label prescribing is legal in Texas and common in medicine generally. However, patients prescribed Ozempic for weight loss are typically capped at the 1 mg or 2 mg dose rather than Wegovy's 2.4 mg, and insurance coverage designed for diabetes medications may not apply if the diagnosis code on file is obesity. This is why many Houston providers shifted to compounded semaglutide or Wegovy once availability improved.

3Insurance Coverage: The Biggest Practical Difference

Insurance coverage differs substantially between the two. Most major commercial plans that cover GLP-1 medications will cover Ozempic for patients with a type 2 diabetes diagnosis, often with manageable copays. Coverage for Wegovy is much more variable - many plans exclude it entirely, require a prior authorization with documented comorbidities, or limit it to certain formulary tiers. Texas Medicaid (STAR) does not cover Wegovy or Ozempic for weight loss at the time of publication. If your Houston clinic accepts insurance and you have type 2 diabetes, Ozempic may be significantly more affordable for you. If you're using semaglutide purely for weight loss, ask your clinic about Wegovy manufacturer savings programs or compounded semaglutide as a cost alternative.

4Compounded Semaglutide: The Third Option Many Houston Clinics Offer

A large share of weight loss clinics in the Houston area - including clinics in Pearland, Cypress, Spring, and League City - now offer compounded semaglutide from FDA-registered 503B compounding pharmacies. Compounded semaglutide is not the same as brand-name Ozempic or Wegovy, is not FDA-approved, and the FDA has raised concerns about some compounding practices. However, when sourced from reputable 503B facilities and prescribed by a licensed physician, it can provide a cost-accessible option. Prices at Houston clinics typically range from $150 to $350 per month for compounded semaglutide, compared to $1,000-$1,350 for brand-name Wegovy without insurance. Ask your provider specifically about the pharmacy source and whether the product includes B12 or other additives.

5Which Should You Ask for at Your Houston Clinic?

If you have type 2 diabetes and insurance that covers Ozempic: talk to your primary care physician or endocrinologist first. You may already qualify at a covered cost. If you're seeking semaglutide for weight loss without diabetes: ask your clinic about Wegovy and whether you qualify for the Novo Nordisk savings card, which can reduce costs to under $25/month for eligible commercially insured patients. If cost is the primary barrier: compounded semaglutide from a physician-supervised Houston clinic may be your most practical starting point, with the understanding that you're using a non-brand product. If your BMI is very high or you have multiple metabolic conditions: consider asking your Houston provider about tirzepatide (Zepbound/Mounjaro), which shows higher average weight loss in head-to-head comparisons.

6The Bottom Line for Houston Patients

The choice between Ozempic and Wegovy is less about which drug is 'better' and more about what you qualify for, what your insurance covers, and what your doctor recommends based on your full medical picture. At physician-supervised clinics across Greater Houston, providers will review your health history, run labs, and help you make a practical, evidence-based decision - not just hand you whatever is cheapest or most popular. Use this directory to find a verified, licensed clinic near you, then go in prepared to ask the right questions.

Ozempic and Wegovy both contain semaglutide, but they differ in approved dose, FDA indication, and insurance coverage. The right choice depends on your diagnosis, insurance plan, and what your Houston physician recommends. Find a qualified provider near you using our directory and start the conversation with confidence.

#Ozempic#Wegovy#semaglutide#GLP-1#medical weight loss Houston#Houston

Sources & References

Clinical data referenced in this article is drawn from the FDA drug database, peer-reviewed publications (STEP trials, SURMOUNT trials), and manufacturer prescribing information for Wegovy, Ozempic, Zepbound, and Mounjaro. Pricing figures reflect publicly available estimates and may vary. Insurance coverage information is general guidance — confirm your specific benefits with your plan.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed physician before starting any weight loss medication or program.